Nine Companies Trade Lower Prices For No Tariffs In Trump’s MFN Drug Pricing Deals

Merck Also Received Two Priority Vouchers

 
• By Mandy Jackson
  
BMS will make anticoagulant Eliquis free for Medicaid, a single-digit percentage of its sales for the product (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Scrip